Skip to main content
NCBI home page
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 2001 Apr 29;356(1408):517–534. doi: 10.1098/rstb.2000.0778

Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

C Boshoff 1, R A Weiss 1
PMCID: PMC1088442  PMID: 11313009

Abstract

Kaposi's sarcoma (KS) occurs in Europe and the Mediterranean countries (classic KS) and Africa (endemic KS), immunosuppressed patients (iatrogenic or post-transplant KS) and those with acquired immune deficiency syndrome (AIDS), especially among those who acquired human immunodeficiency virus sexually (AIDS-KS). KS-associated herpesvirus (KSHV or HHV-8) is unusual among herpesviruses in having a restricted geographical distribution. Like KS, which it induces in immunosuppressed or elderly people, the virus is prevalent in Africa, in Mediterranean countries, among Jews and Arabs and certain Amerindians. Distinct KSHV genotypes occur in different parts of the world, but have not been identified as having a differential pathogenesis. KSHV is aetiologically linked to three distinct neoplasms: (i) KS, (ii) primary effusion lymphoma, and (iii) plasmablastic multicentric Castleman's disease. The histogenesis, clonality and pathology of the tumours are described, together with the epidemiology and possible modes of transmission of the virus.

Full Text

The Full Text of this article is available as a PDF (4.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams V., Kempf W., Schmid M., Müller B., Briner J., Burg G. Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet. 1995 Dec 23;346(8991-8992):1715–1716. doi: 10.1016/s0140-6736(95)92887-1. [DOI] [PubMed] [Google Scholar]
  2. Albini A., Barillari G., Benelli R., Gallo R. C., Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4838–4842. doi: 10.1073/pnas.92.11.4838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Albini A., Benelli R., Presta M., Rusnati M., Ziche M., Rubartelli A., Paglialunga G., Bussolino F., Noonan D. HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene. 1996 Jan 18;12(2):289–297. [PubMed] [Google Scholar]
  4. Albini A., Soldi R., Giunciuglio D., Giraudo E., Benelli R., Primo L., Noonan D., Salio M., Camussi G., Rockl W. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med. 1996 Dec;2(12):1371–1375. doi: 10.1038/nm1296-1371. [DOI] [PubMed] [Google Scholar]
  5. Ambroziak J. A., Blackbourn D. J., Herndier B. G., Glogau R. G., Gullett J. H., McDonald A. R., Lennette E. T., Levy J. A. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science. 1995 Apr 28;268(5210):582–583. doi: 10.1126/science.7725108. [DOI] [PubMed] [Google Scholar]
  6. Andreoni M., El-Sawaf G., Rezza G., Ensoli B., Nicastri E., Ventura L., Ercoli L., Sarmati L., Rocchi G. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst. 1999 Mar 3;91(5):465–469. doi: 10.1093/jnci/91.5.465. [DOI] [PubMed] [Google Scholar]
  7. Ariyoshi K., Schim van der Loeff M., Cook P., Whitby D., Corrah T., Jaffar S., Cham F., Sabally S., O'Donovan D., Weiss R. A. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol. 1998 Mar-Apr;1(3):193–199. [PubMed] [Google Scholar]
  8. Arvanitakis L., Mesri E. A., Nador R. G., Said J. W., Asch A. S., Knowles D. M., Cesarman E. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood. 1996 Oct 1;88(7):2648–2654. [PubMed] [Google Scholar]
  9. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997 Feb 14;275(5302):964–967. doi: 10.1126/science.275.5302.964. [DOI] [PubMed] [Google Scholar]
  10. Ballestas M. E., Chatis P. A., Kaye K. M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 1999 Apr 23;284(5414):641–644. doi: 10.1126/science.284.5414.641. [DOI] [PubMed] [Google Scholar]
  11. Bar-Sade R. B., Kruglikova A., Modan B., Gak E., Hirsh-Yechezkel G., Theodor L., Novikov I., Gershoni-Baruch R., Risel S., Papa M. Z. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum Mol Genet. 1998 May;7(5):801–805. doi: 10.1093/hmg/7.5.801. [DOI] [PubMed] [Google Scholar]
  12. Barnett S. W., Murthy K. K., Herndier B. G., Levy J. A. An AIDS-like condition induced in baboons by HIV-2. Science. 1994 Oct 28;266(5185):642–646. doi: 10.1126/science.7939718. [DOI] [PubMed] [Google Scholar]
  13. Bassett M. T., Chokunonga E., Mauchaza B., Levy L., Ferlay J., Parkin D. M. Cancer in the African population of Harare, Zimbabwe, 1990-1992. Int J Cancer. 1995 Sep 27;63(1):29–36. doi: 10.1002/ijc.2910630107. [DOI] [PubMed] [Google Scholar]
  14. Ben-Chetrit E., Levy M. Familial Mediterranean fever. Lancet. 1998 Feb 28;351(9103):659–664. doi: 10.1016/S0140-6736(97)09408-7. [DOI] [PubMed] [Google Scholar]
  15. Beral V., Peterman T. A., Berkelman R. L., Jaffe H. W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990 Jan 20;335(8682):123–128. doi: 10.1016/0140-6736(90)90001-l. [DOI] [PubMed] [Google Scholar]
  16. Biggar R. J., Horm J., Fraumeni J. F., Jr, Greene M. H., Goedert J. J. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst. 1984 Jul;73(1):89–94. [PubMed] [Google Scholar]
  17. Biggar R. J., Whitby D., Marshall V., Linhares A. C., Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis. 2000 May 8;181(5):1562–1568. doi: 10.1086/315456. [DOI] [PubMed] [Google Scholar]
  18. Boshoff C., Schulz T. F., Kennedy M. M., Graham A. K., Fisher C., Thomas A., McGee J. O., Weiss R. A., O'Leary J. J. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med. 1995 Dec;1(12):1274–1278. doi: 10.1038/nm1295-1274. [DOI] [PubMed] [Google Scholar]
  19. Boshoff C., Talbot S., Kennedy M., O'Leary J., Schulz T., Chang Y. HHV8 and skin cancers in immunosuppressed patients. Lancet. 1996 Feb 3;347(8997):338–339. doi: 10.1016/s0140-6736(96)90524-3. [DOI] [PubMed] [Google Scholar]
  20. Boshoff C., Whitby D., Hatziioannou T., Fisher C., van der Walt J., Hatzakis A., Weiss R., Schulz T. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet. 1995 Apr 22;345(8956):1043–1044. doi: 10.1016/s0140-6736(95)90780-7. [DOI] [PubMed] [Google Scholar]
  21. Bourboulia D., Whitby D., Boshoff C., Newton R., Beral V., Carrara H., Lane A., Sitas F. Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection. JAMA. 1998 Jul 1;280(1):31–32. doi: 10.1001/jama.280.1.31-a. [DOI] [PubMed] [Google Scholar]
  22. Browning P. J., Sechler J. M., Kaplan M., Washington R. H., Gendelman R., Yarchoan R., Ensoli B., Gallo R. C. Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls. Blood. 1994 Oct 15;84(8):2711–2720. [PubMed] [Google Scholar]
  23. Buonaguro F. M., Tornesello M. L., Beth-Giraldo E., Hatzakis A., Mueller N., Downing R., Biryamwaho B., Sempala S. D., Giraldo G. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer. 1996 Jan 3;65(1):25–28. doi: 10.1002/(SICI)1097-0215(19960103)65:1<25::AID-IJC5>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  24. CASTLEMAN B., IVERSON L., MENENDEZ V. P. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956 Jul-Aug;9(4):822–830. doi: 10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  25. Calabrò M. L., Sheldon J., Favero A., Simpson G. R., Fiore J. R., Gomes E., Angarano G., Chieco-Bianchi L., Schulz T. F. Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol. 1998 Mar-Apr;1(3):207–213. [PubMed] [Google Scholar]
  26. Cathomas G., McGandy C. E., Terracciano L. M., Itin P. H., De Rosa G., Gudat F. Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma. J Clin Pathol. 1996 Aug;49(8):631–633. doi: 10.1136/jcp.49.8.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Cattani P., Capuano M., Cerimele F., La Parola I. L., Santangelo R., Masini C., Cerimele D., Fadda G. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol. 1999 Apr;37(4):1150–1153. doi: 10.1128/jcm.37.4.1150-1153.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995 May 4;332(18):1186–1191. doi: 10.1056/NEJM199505043321802. [DOI] [PubMed] [Google Scholar]
  29. Chadburn A., Cesarman E., Nador R. G., Liu Y. F., Knowles D. M. Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer. 1997 Aug 15;80(4):788–797. [PubMed] [Google Scholar]
  30. Chandran B., Smith M. S., Koelle D. M., Corey L., Horvat R., Goldstein E. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology. 1998 Mar 30;243(1):208–217. doi: 10.1006/viro.1998.9055. [DOI] [PubMed] [Google Scholar]
  31. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994 Dec 16;266(5192):1865–1869. doi: 10.1126/science.7997879. [DOI] [PubMed] [Google Scholar]
  32. Chang Y., Ziegler J., Wabinga H., Katangole-Mbidde E., Boshoff C., Schulz T., Whitby D., Maddalena D., Jaffe H. W., Weiss R. A. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med. 1996 Jan 22;156(2):202–204. [PubMed] [Google Scholar]
  33. Chatlynne L. G., Lapps W., Handy M., Huang Y. Q., Masood R., Hamilton A. S., Said J. W., Koeffler H. P., Kaplan M. H., Friedman-Kien A. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood. 1998 Jul 1;92(1):53–58. [PubMed] [Google Scholar]
  34. Chuck S., Grant R. M., Katongole-Mbidde E., Conant M., Ganem D. Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis. 1996 Jan;173(1):248–251. doi: 10.1093/infdis/173.1.248. [DOI] [PubMed] [Google Scholar]
  35. Codish S., Abu-Shakra M., Ariad S., Zirkin H. J., Yermiyahu T., Dupin N., Boshoff C., Sukenik S. Manifestations of three HHV-8-related diseases in an HIV-negative patient: immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma. Am J Hematol. 2000 Dec;65(4):310–314. doi: 10.1002/1096-8652(200012)65:4<310::aid-ajh11>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  36. Cook P. M., Whitby D., Calabro M. L., Luppi M., Kakoola D. N., Hjalgrim H., Ariyoshi K., Ensoli B., Davison A. J., Schulz T. F. Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group. AIDS. 1999 Jul 9;13(10):1165–1176. doi: 10.1097/00002030-199907090-00004. [DOI] [PubMed] [Google Scholar]
  37. Corbellino M., Bestetti G., Galli M., Parravicini C. Absence of HHV-8 in prostate and semen. N Engl J Med. 1996 Oct 17;335(16):1237–1239. doi: 10.1056/NEJM199610173351614. [DOI] [PubMed] [Google Scholar]
  38. Corbellino M., Poirel L., Aubin J. T., Paulli M., Magrini U., Bestetti G., Galli M., Parravicini C. The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease). Clin Infect Dis. 1996 Jun;22(6):1120–1121. doi: 10.1093/clinids/22.6.1120. [DOI] [PubMed] [Google Scholar]
  39. Cotter M. A., 2nd, Robertson E. S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology. 1999 Nov 25;264(2):254–264. doi: 10.1006/viro.1999.9999. [DOI] [PubMed] [Google Scholar]
  40. Cottoni F., De Marco R., Montesu M. A. Classical Kaposi's sarcoma in north-east Sardinia: an overview from 1977 to 1991. Br J Cancer. 1996 May;73(9):1132–1133. doi: 10.1038/bjc.1996.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. D'Oliveira J. J., Torres F. O. Kaposi's sarcoma in the Bantu of Mozambique. Cancer. 1972 Aug;30(2):553–561. doi: 10.1002/1097-0142(197208)30:2<553::aid-cncr2820300236>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  42. Davidovici B., Karakis I., Bourboulia D., Ariad S., Zong J., Benharroch D., Dupin N., Weiss R., Hayward G., Sarov B. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst. 2001 Feb 7;93(3):194–202. doi: 10.1093/jnci/93.3.194. [DOI] [PubMed] [Google Scholar]
  43. Davis D. A., Humphrey R. W., Newcomb F. M., O'Brien T. R., Goedert J. J., Straus S. E., Yarchoan R. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide. J Infect Dis. 1997 May;175(5):1071–1079. doi: 10.1086/516444. [DOI] [PubMed] [Google Scholar]
  44. Delabesse E., Oksenhendler E., Lebbé C., Vérola O., Varet B., Turhan A. G. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol. 1997 Aug;50(8):664–668. doi: 10.1136/jcp.50.8.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Desrosiers R. C., Sasseville V. G., Czajak S. C., Zhang X., Mansfield K. G., Kaur A., Johnson R. P., Lackner A. A., Jung J. U. A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol. 1997 Dec;71(12):9764–9769. doi: 10.1128/jvi.71.12.9764-9769.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Di Alberti L., Piattelli A., Artese L., Favia G., Patel S., Saunders N., Porter S. R., Scully C. M., Ngui S. L., Teo C. G. Human herpesvirus 8 variants in sarcoid tissues. Lancet. 1997 Dec 6;350(9092):1655–1661. doi: 10.1016/s0140-6736(97)10102-7. [DOI] [PubMed] [Google Scholar]
  47. Diamond C., Brodie S. J., Krieger J. N., Huang M. L., Koelle D. M., Diem K., Muthui D., Corey L. Human herpesvirus 8 in the prostate glands of men with Kaposi's sarcoma. J Virol. 1998 Jul;72(7):6223–6227. doi: 10.1128/jvi.72.7.6223-6227.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Dictor M., Rambech E., Way D., Witte M., Bendsöe N. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol. 1996 Jun;148(6):2009–2016. [PMC free article] [PubMed] [Google Scholar]
  49. Dukers N. H., Renwick N., Prins M., Geskus R. B., Schulz T. F., Weverling G. J., Coutinho R. A., Goudsmit J. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol. 2000 Feb 1;151(3):213–224. doi: 10.1093/oxfordjournals.aje.a010195. [DOI] [PubMed] [Google Scholar]
  50. Dupin N., Diss T. L., Kellam P., Tulliez M., Du M. Q., Sicard D., Weiss R. A., Isaacson P. G., Boshoff C. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000 Feb 15;95(4):1406–1412. [PubMed] [Google Scholar]
  51. Dupin N., Fisher C., Kellam P., Ariad S., Tulliez M., Franck N., van Marck E., Salmon D., Gorin I., Escande J. P. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4546–4551. doi: 10.1073/pnas.96.8.4546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Dupin N., Grandadam M., Calvez V., Gorin I., Aubin J. T., Havard S., Lamy F., Leibowitch M., Huraux J. M., Escande J. P. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet. 1995 Mar 25;345(8952):761–762. doi: 10.1016/s0140-6736(95)90642-8. [DOI] [PubMed] [Google Scholar]
  53. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P., Gallo R. C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol. 1993 Jan;67(1):277–287. doi: 10.1128/jvi.67.1.277-287.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Ensoli B., Gendelman R., Markham P., Fiorelli V., Colombini S., Raffeld M., Cafaro A., Chang H. K., Brady J. N., Gallo R. C. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 1994 Oct 20;371(6499):674–680. doi: 10.1038/371674a0. [DOI] [PubMed] [Google Scholar]
  55. Ensoli B., Salahuddin S. Z., Gallo R. C. AIDS-associated Kaposi's sarcoma: a molecular model for its pathogenesis. Cancer Cells. 1989 Nov;1(3):93–96. [PubMed] [Google Scholar]
  56. Farge D. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med. 1993 Jun-Jul;2(6):339–343. [PubMed] [Google Scholar]
  57. Fenig E., Brenner B., Rakowsky E., Lapidoth M., Katz A., Sulkes A. Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel. Am J Clin Oncol. 1998 Oct;21(5):498–500. doi: 10.1097/00000421-199810000-00016. [DOI] [PubMed] [Google Scholar]
  58. Fiorelli V., Gendelman R., Sirianni M. C., Chang H. K., Colombini S., Markham P. D., Monini P., Sonnabend J., Pintus A., Gallo R. C. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood. 1998 Feb 1;91(3):956–967. [PubMed] [Google Scholar]
  59. Flore O., Rafii S., Ely S., O'Leary J. J., Hyjek E. M., Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature. 1998 Aug 6;394(6693):588–592. doi: 10.1038/29093. [DOI] [PubMed] [Google Scholar]
  60. Franceschi S., Geddes M. Epidemiology of classic Kaposi's sarcoma, with special reference to mediterranean population. Tumori. 1995 Sep-Oct;81(5):308–314. doi: 10.1177/030089169508100502. [DOI] [PubMed] [Google Scholar]
  61. Franceschi S., Serraino D. Kaposi's sarcoma and KSHV. Lancet. 1995 Nov 18;346(8986):1360–1361. [PubMed] [Google Scholar]
  62. Frankel A. D., Pabo C. O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 1988 Dec 23;55(6):1189–1193. doi: 10.1016/0092-8674(88)90263-2. [DOI] [PubMed] [Google Scholar]
  63. Friborg J., Jr, Kong W., Hottiger M. O., Nabel G. J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature. 1999 Dec 23;402(6764):889–894. doi: 10.1038/47266. [DOI] [PubMed] [Google Scholar]
  64. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol. 1988 Nov;5(4):346–364. [PubMed] [Google Scholar]
  65. Gaidano G., Capello D., Cilia A. M., Gloghini A., Perin T., Quattrone S., Migliazza A., Lo Coco F., Saglio G., Ascoli V. Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis. Genes Chromosomes Cancer. 1999 Jan;24(1):16–23. doi: 10.1002/(sici)1098-2264(199901)24:1<16::aid-gcc3>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  66. Gaidano G., Pastore C., Gloghini A., Cusini M., Nomdedéu J., Volpe G., Capello D., Vaccher E., Bordes R., Tirelli U. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS. 1996 Aug;10(9):941–949. doi: 10.1097/00002030-199610090-00003. [DOI] [PubMed] [Google Scholar]
  67. Gallo R. C. The enigmas of Kaposi's sarcoma. Science. 1998 Dec 4;282(5395):1837–1839. doi: 10.1126/science.282.5395.1837. [DOI] [PubMed] [Google Scholar]
  68. Gao S. J., Kingsley L., Hoover D. R., Spira T. J., Rinaldo C. R., Saah A., Phair J., Detels R., Parry P., Chang Y. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med. 1996 Jul 25;335(4):233–241. doi: 10.1056/NEJM199607253350403. [DOI] [PubMed] [Google Scholar]
  69. Gao S. J., Kingsley L., Li M., Zheng W., Parravicini C., Ziegler J., Newton R., Rinaldo C. R., Saah A., Phair J. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 1996 Aug;2(8):925–928. doi: 10.1038/nm0896-925. [DOI] [PubMed] [Google Scholar]
  70. Geddes M., Franceschi S., Balzi D., Arniani S., Gafà L., Zanetti R. Birthplace and classic Kaposi's sarcoma in Italy. Associazione Italiana Registri Tumori. J Natl Cancer Inst. 1995 Jul 5;87(13):1015–1017. doi: 10.1093/jnci/87.13.1015. [DOI] [PubMed] [Google Scholar]
  71. Gessain A., Brière J., Angelin-Duclos C., Valensi F., Béral H. M., Davi F., Nicola M. A., Sudaka A., Fouchard N., Gabarre J. Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas. Leukemia. 1997 Feb;11(2):266–272. doi: 10.1038/sj.leu.2400549. [DOI] [PubMed] [Google Scholar]
  72. Gessain A., Sudaka A., Brière J., Fouchard N., Nicola M. A., Rio B., Arborio M., Troussard X., Audouin J., Diebold J. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood. 1996 Jan 1;87(1):414–416. [PubMed] [Google Scholar]
  73. Gill P. S., Tsai Y. C., Rao A. P., Spruck C. H., 3rd, Zheng T., Harrington W. A., Jr, Cheung T., Nathwani B., Jones P. A. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8257–8261. doi: 10.1073/pnas.95.14.8257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Giraldo G., Beth E., Haguenau F. Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst. 1972 Dec;49(6):1509–1526. doi: 10.1093/jnci/49.6.1509. [DOI] [PubMed] [Google Scholar]
  75. Giraldo G., Beth E., Kourilsky F. M., Henle W., Henle G., Miké V., Huraux J. M., Andersen H. K., Gharbi M. R., Kyalwazi S. K. Antibody patterns to herpesviruses in kaposi's sarcoma: serological association of european kaposi's sarcoma with cytomegalovirus. Int J Cancer. 1975 May 15;15(5):839–848. doi: 10.1002/ijc.2910150516. [DOI] [PubMed] [Google Scholar]
  76. Greensill J., Sheldon J. A., Renwick N. M., Beer B. E., Norley S., Goudsmit J., Schulz T. F. Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates? J Virol. 2000 Feb;74(3):1572–1577. doi: 10.1128/jvi.74.3.1572-1577.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Grulich A. E., Beral V., Swerdlow A. J. Kaposi's sarcoma in England and Wales before the AIDS epidemic. Br J Cancer. 1992 Dec;66(6):1135–1137. doi: 10.1038/bjc.1992.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Harwood A. R., Osoba D., Hofstader S. L., Goldstein M. B., Cardella C. J., Holecek M. J., Kunynetz R., Giammarco R. A. Kaposi's sarcoma in recipients of renal transplants. Am J Med. 1979 Nov;67(5):759–765. doi: 10.1016/0002-9343(79)90731-9. [DOI] [PubMed] [Google Scholar]
  79. Hayward G. S. KSHV strains: the origins and global spread of the virus. Semin Cancer Biol. 1999 Jun;9(3):187–199. doi: 10.1006/scbi.1998.0116. [DOI] [PubMed] [Google Scholar]
  80. He J., Bhat G., Kankasa C., Chintu C., Mitchell C., Duan W., Wood C. Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. J Infect Dis. 1998 Dec;178(6):1787–1790. doi: 10.1086/314512. [DOI] [PubMed] [Google Scholar]
  81. Howard M. R., Whitby D., Bahadur G., Suggett F., Boshoff C., Tenant-Flowers M., Schulz T. F., Kirk S., Matthews S., Weller I. V. Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS. 1997 Feb;11(2):F15–F19. doi: 10.1097/00002030-199702000-00001. [DOI] [PubMed] [Google Scholar]
  82. Huang Y. Q., Li J. J., Rush M. G., Poiesz B. J., Nicolaides A., Jacobson M., Zhang W. G., Coutavas E., Abbott M. A., Friedman-Kien A. E. HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet. 1992 Feb 29;339(8792):515–518. doi: 10.1016/0140-6736(92)90338-4. [DOI] [PubMed] [Google Scholar]
  83. Iscovich J., Boffetta P., Winkelmann R., Brennan P., Azizi E. Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study. AIDS. 1998 Oct 22;12(15):2067–2072. doi: 10.1097/00002030-199815000-00019. [DOI] [PubMed] [Google Scholar]
  84. Jenner R. G., Albà M. M., Boshoff C., Kellam P. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol. 2001 Jan;75(2):891–902. doi: 10.1128/JVI.75.2.891-902.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Jin Y. T., Tsai S. T., Yan J. J., Hsiao J. H., Lee Y. Y., Su I. J. Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequence in vascular lesions. A reliable diagnostic marker for Kaposi's sarcoma. Am J Clin Pathol. 1996 Mar;105(3):360–363. doi: 10.1093/ajcp/105.3.360. [DOI] [PubMed] [Google Scholar]
  86. Jones D., Ballestas M. E., Kaye K. M., Gulizia J. M., Winters G. L., Fletcher J., Scadden D. T., Aster J. C. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med. 1998 Aug 13;339(7):444–449. doi: 10.1056/NEJM199808133390705. [DOI] [PubMed] [Google Scholar]
  87. Judde J. G., Lacoste V., Brière J., Kassa-Kelembho E., Clyti E., Couppié P., Buchrieser C., Tulliez M., Morvan J., Gessain A. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst. 2000 May 3;92(9):729–736. doi: 10.1093/jnci/92.9.729. [DOI] [PubMed] [Google Scholar]
  88. Jussila L., Valtola R., Partanen T. A., Salven P., Heikkilä P., Matikainen M. T., Renkonen R., Kaipainen A., Detmar M., Tschachler E. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 1998 Apr 15;58(8):1599–1604. [PubMed] [Google Scholar]
  89. Katano H., Sato Y., Kurata T., Mori S., Sata T. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology. 2000 Apr 10;269(2):335–344. doi: 10.1006/viro.2000.0196. [DOI] [PubMed] [Google Scholar]
  90. Kedes D. H., Ganem D., Ameli N., Bacchetti P., Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA. 1997 Feb 12;277(6):478–481. [PubMed] [Google Scholar]
  91. Kedes D. H., Lagunoff M., Renne R., Ganem D. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest. 1997 Nov 15;100(10):2606–2610. doi: 10.1172/JCI119804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Kedes D. H., Operskalski E., Busch M., Kohn R., Flood J., Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996 Aug;2(8):918–924. doi: 10.1038/nm0896-918. [DOI] [PubMed] [Google Scholar]
  93. Kellam P., Boshoff C., Whitby D., Matthews S., Weiss R. A., Talbot S. J. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol. 1997 Nov-Dec;1(1):19–29. [PubMed] [Google Scholar]
  94. Kellam P., Bourboulia D., Dupin N., Shotton C., Fisher C., Talbot S., Boshoff C., Weiss R. A. Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8. J Virol. 1999 Jun;73(6):5149–5155. doi: 10.1128/jvi.73.6.5149-5155.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Kempf W., Adams V., Pfaltz M., Briner J., Schmid M., Moos R., Hassam S. Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi's sarcoma: no evidence for an etiological association. Hum Pathol. 1995 Aug;26(8):914–919. doi: 10.1016/0046-8177(95)90016-0. [DOI] [PubMed] [Google Scholar]
  96. Knowles D. M., Inghirami G., Ubriaco A., Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood. 1989 Feb 15;73(3):792–799. [PubMed] [Google Scholar]
  97. Koelle D. M., Huang M. L., Chandran B., Vieira J., Piepkorn M., Corey L. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis. 1997 Jul;176(1):94–102. doi: 10.1086/514045. [DOI] [PubMed] [Google Scholar]
  98. Komanduri K. V., Luce J. A., McGrath M. S., Herndier B. G., Ng V. L. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 1;13(3):215–226. doi: 10.1097/00042560-199611010-00003. [DOI] [PubMed] [Google Scholar]
  99. Koulibaly M., Kabba I. S., Cissé A., Diallo S. B., Diallo M. B., Keita N., Camara N. D., Diallo M. S., Sylla B. S., Parkin D. M. Cancer incidence in Conakry, Guinea: first results from the Cancer Registry 1992-1995. Int J Cancer. 1997 Jan 6;70(1):39–45. doi: 10.1002/(sici)1097-0215(19970106)70:1<39::aid-ijc6>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  100. Lacoste V., Kadyrova E., Chistiakova I., Gurtsevitch V., Judde J. G., Gessain A. Molecular characterization of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 strains from Russia. J Gen Virol. 2000 May;81(Pt 5):1217–1222. doi: 10.1099/0022-1317-81-5-1217. [DOI] [PubMed] [Google Scholar]
  101. Lacoste V., Mauclère P., Dubreuil G., Lewis J., Georges-Courbot M. C., Gessain A. KSHV-like herpesviruses in chimps and gorillas. Nature. 2000 Sep 14;407(6801):151–152. doi: 10.1038/35025145. [DOI] [PubMed] [Google Scholar]
  102. Lebbé C., Agbalika F., de Crémoux P., Deplanche M., Rybojad M., Masgrau E., Morel P., Calvo F. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma. Arch Dermatol. 1997 Jan;133(1):25–30. [PubMed] [Google Scholar]
  103. Lennette E. T., Blackbourn D. J., Levy J. A. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet. 1996 Sep 28;348(9031):858–861. doi: 10.1016/S0140-6736(96)03240-0. [DOI] [PubMed] [Google Scholar]
  104. Li J. J., Huang Y. Q., Cockerell C. J., Friedman-Kien A. E. Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Am J Pathol. 1996 Jun;148(6):1741–1748. [PMC free article] [PubMed] [Google Scholar]
  105. Li L., Hoffman R. M. The feasibility of targeted selective gene therapy of the hair follicle. Nat Med. 1995 Jul;1(7):705–706. doi: 10.1038/nm0795-705. [DOI] [PubMed] [Google Scholar]
  106. Lin B. T., Chen Y. Y., Battifora H., Weiss L. M. Absence of Kaposi's sarcoma-associated herpesvirus-like DNA sequences in malignant vascular tumors of the serous membranes. Mod Pathol. 1996 Dec;9(12):1143–1146. [PubMed] [Google Scholar]
  107. Lin J. C., Lin S. C., Mar E. C., Pellett P. E., Stamey F. R., Stewart J. A., Spira T. J. Retraction: Is Kaposi's sarcoma-associated herpesvirus in semen of HIV-infected homosexual men? Lancet. 1998 May 2;351(9112):1365–1365. doi: 10.1016/S0140-6736(05)79106-6. [DOI] [PubMed] [Google Scholar]
  108. Luppi M., Barozzi P., Maiorana A., Collina G., Ferrari M. G., Marasca R., Morselli M., Rossi E., Ceccherini-Nelli L., Torelli G. Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissues from an Italian population. Int J Cancer. 1996 May 16;66(4):427–431. doi: 10.1002/(SICI)1097-0215(19960516)66:4<427::AID-IJC3>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  109. Marchiò S., Primo L., Pagano M., Palestro G., Albini A., Veikkola T., Cascone I., Alitalo K., Bussolino F. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem. 1999 Sep 24;274(39):27617–27622. doi: 10.1074/jbc.274.39.27617. [DOI] [PubMed] [Google Scholar]
  110. Martin J. N., Ganem D. E., Osmond D. H., Page-Shafer K. A., Macrae D., Kedes D. H. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998 Apr 2;338(14):948–954. doi: 10.1056/NEJM199804023381403. [DOI] [PubMed] [Google Scholar]
  111. Mayama S., Cuevas L. E., Sheldon J., Omar O. H., Smith D. H., Okong P., Silvel B., Hart C. A., Schulz T. F. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer. 1998 Sep 11;77(6):817–820. doi: 10.1002/(sici)1097-0215(19980911)77:6<817::aid-ijc2>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  112. McDonagh D. P., Liu J., Gaffey M. J., Layfield L. J., Azumi N., Traweek S. T. Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequence in angiosarcoma. Am J Pathol. 1996 Oct;149(4):1363–1368. [PMC free article] [PubMed] [Google Scholar]
  113. McGeoch D. J., Davison A. J. The descent of human herpesvirus 8. Semin Cancer Biol. 1999 Jun;9(3):201–209. doi: 10.1006/scbi.1999.0093. [DOI] [PubMed] [Google Scholar]
  114. Meng Y. X., Spira T. J., Bhat G. J., Birch C. J., Druce J. D., Edlin B. R., Edwards R., Gunthel C., Newton R., Stamey F. R. Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology. 1999 Aug 15;261(1):106–119. doi: 10.1006/viro.1999.9853. [DOI] [PubMed] [Google Scholar]
  115. Miles S. A., Rezai A. R., Salazar-González J. F., Vander Meyden M., Stevens R. H., Logan D. M., Mitsuyasu R. T., Taga T., Hirano T., Kishimoto T. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4068–4072. doi: 10.1073/pnas.87.11.4068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Monini P., Rotola A., de Lellis L., Corallini A., Secchiero P., Albini A., Benelli R., Parravicini C., Barbanti-Brodano G., Cassai E. Latent BK virus infection and Kaposi's sarcoma pathogenesis. Int J Cancer. 1996 Jun 11;66(6):717–722. doi: 10.1002/(SICI)1097-0215(19960611)66:6<717::AID-IJC1>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  117. Monini P., de Lellis L., Fabris M., Rigolin F., Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med. 1996 May 2;334(18):1168–1172. doi: 10.1056/NEJM199605023341805. [DOI] [PubMed] [Google Scholar]
  118. Moore P. S., Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med. 1995 May 4;332(18):1181–1185. doi: 10.1056/NEJM199505043321801. [DOI] [PubMed] [Google Scholar]
  119. Moore P. S., Kingsley L. A., Holmberg S. D., Spira T., Gupta P., Hoover D. R., Parry J. P., Conley L. J., Jaffe H. W., Chang Y. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS. 1996 Feb;10(2):175–180. doi: 10.1097/00002030-199602000-00007. [DOI] [PubMed] [Google Scholar]
  120. Moses A. V., Fish K. N., Ruhl R., Smith P. P., Strussenberg J. G., Zhu L., Chandran B., Nelson J. A. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol. 1999 Aug;73(8):6892–6902. doi: 10.1128/jvi.73.8.6892-6902.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Nador R. G., Cesarman E., Chadburn A., Dawson D. B., Ansari M. Q., Sald J., Knowles D. M. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996 Jul 15;88(2):645–656. [PubMed] [Google Scholar]
  122. Nair B. C., DeVico A. L., Nakamura S., Copeland T. D., Chen Y., Patel A., O'Neil T., Oroszlan S., Gallo R. C., Sarngadharan M. G. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science. 1992 Mar 13;255(5050):1430–1432. doi: 10.1126/science.1542792. [DOI] [PubMed] [Google Scholar]
  123. Newton R., Ngilimana P. J., Grulich A., Beral V., Sindikubwabo B., Nganyira A., Parkin D. M. Cancer in Rwanda. Int J Cancer. 1996 Mar 28;66(1):75–81. doi: 10.1002/(SICI)1097-0215(19960328)66:1<75::AID-IJC14>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  124. Nicholas J., Zong J. C., Alcendor D. J., Ciufo D. M., Poole L. J., Sarisky R. T., Chiou C. J., Zhang X., Wan X., Guo H. G. Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8. J Natl Cancer Inst Monogr. 1998;(23):79–88. doi: 10.1093/oxfordjournals.jncimonographs.a024179. [DOI] [PubMed] [Google Scholar]
  125. Nickoloff B. J., Griffiths C. E. The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes. Am J Pathol. 1989 Nov;135(5):793–800. [PMC free article] [PubMed] [Google Scholar]
  126. O'Brien T. R., Kedes D., Ganem D., Macrae D. R., Rosenberg P. S., Molden J., Goedert J. J. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis. 1999 Oct;180(4):1010–1017. doi: 10.1086/315039. [DOI] [PubMed] [Google Scholar]
  127. O'Neill E., Henson T. H., Ghorbani A. J., Land M. A., Webber B. L., Garcia J. V. Herpes virus-like sequences are specifically found in Kaposi sarcoma lesions. J Clin Pathol. 1996 Apr;49(4):306–308. doi: 10.1136/jcp.49.4.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Oksenhendler E., Cazals-Hatem D., Schulz T. F., Barateau V., Grollet L., Sheldon J., Clauvel J. P., Sigaux F., Agbalika F. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med. 1998 May 28;338(22):1585–1590. doi: 10.1056/NEJM199805283382204. [DOI] [PubMed] [Google Scholar]
  129. Olsen S. J., Chang Y., Moore P. S., Biggar R. J., Melbye M. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS. 1998 Oct 1;12(14):1921–1925. doi: 10.1097/00002030-199814000-00024. [DOI] [PubMed] [Google Scholar]
  130. Olweny C. L., Kaddumukasa A., Atine I., Owor R., Magrath I., Ziegler J. L. Childhood Kaposi's sarcoma: clinical features and therapy. Br J Cancer. 1976 May;33(5):555–560. doi: 10.1038/bjc.1976.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Parkin D. M., Wabinga H., Nambooze S., Wabwire-Mangen F. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS. 1999 Dec 24;13(18):2563–2570. doi: 10.1097/00002030-199912240-00010. [DOI] [PubMed] [Google Scholar]
  132. Parravicini C., Chandran B., Corbellino M., Berti E., Paulli M., Moore P. S., Chang Y. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol. 2000 Mar;156(3):743–749. doi: 10.1016/S0002-9440(10)64940-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Parravicini C., Lauri E., Baldini L., Neri A., Poli F., Sirchia G., Moroni M., Galli M., Corbellino M. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science. 1997 Dec 12;278(5345):1969–1973. doi: 10.1126/science.278.5345.1969. [DOI] [PubMed] [Google Scholar]
  134. Pellett P. E., Spira T. J., Bagasra O., Boshoff C., Corey L., de Lellis L., Huang M. L., Lin J. C., Matthews S., Monini P. Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol. 1999 May;37(5):1298–1301. doi: 10.1128/jcm.37.5.1298-1301.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Penn I. Kaposi's sarcoma in immunosuppressed patients. J Clin Lab Immunol. 1983 Sep;12(1):1–10. [PubMed] [Google Scholar]
  136. Petersen G. M., Rotter J. I., Cantor R. M., Field L. L., Greenwald S., Lim J. S., Roy C., Schoenfeld V., Lowden J. A., Kaback M. M. The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin. Am J Hum Genet. 1983 Nov;35(6):1258–1269. [PMC free article] [PubMed] [Google Scholar]
  137. Plancoulaine S., Abel L., van Beveren M., Trégouët D. A., Joubert M., Tortevoye P., de Thé G., Gessain A. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet. 2000 Sep 23;356(9235):1062–1065. doi: 10.1016/S0140-6736(00)02729-X. [DOI] [PubMed] [Google Scholar]
  138. Platt G. M., Simpson G. R., Mittnacht S., Schulz T. F. Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J Virol. 1999 Dec;73(12):9789–9795. doi: 10.1128/jvi.73.12.9789-9795.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Poole L. J., Zong J. C., Ciufo D. M., Alcendor D. J., Cannon J. S., Ambinder R., Orenstein J. M., Reitz M. S., Hayward G. S. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol. 1999 Aug;73(8):6646–6660. doi: 10.1128/jvi.73.8.6646-6660.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Prakash O., Tang Z. Y., He Y. E., Ali M. S., Coleman R., Gill J., Farr G., Samaniego F. Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice. J Natl Cancer Inst. 2000 May 3;92(9):721–728. doi: 10.1093/jnci/92.9.721. [DOI] [PubMed] [Google Scholar]
  141. Qunibi W., Akhtar M., Sheth K., Ginn H. E., Al-Furayh O., DeVol E. B., Taher S. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med. 1988 Feb;84(2):225–232. doi: 10.1016/0002-9343(88)90418-4. [DOI] [PubMed] [Google Scholar]
  142. Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 1986 Dec 26;47(6):883–889. doi: 10.1016/0092-8674(86)90803-2. [DOI] [PubMed] [Google Scholar]
  143. Raab M. S., Albrecht J. C., Birkmann A., Yağuboğlu S., Lang D., Fleckenstein B., Neipel F. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol. 1998 Aug;72(8):6725–6731. doi: 10.1128/jvi.72.8.6725-6731.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Rabkin C. S., Bedi G., Musaba E., Sunkutu R., Mwansa N., Sidransky D., Biggar R. J. AIDS-related Kaposi's sarcoma is a clonal neoplasm. Clin Cancer Res. 1995 Mar;1(3):257–260. [PubMed] [Google Scholar]
  145. Rabkin C. S., Janz S., Lash A., Coleman A. E., Musaba E., Liotta L., Biggar R. J., Zhuang Z. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med. 1997 Apr 3;336(14):988–993. doi: 10.1056/NEJM199704033361403. [DOI] [PubMed] [Google Scholar]
  146. Radkov S. A., Kellam P., Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med. 2000 Oct;6(10):1121–1127. doi: 10.1038/80459. [DOI] [PubMed] [Google Scholar]
  147. Rainbow L., Platt G. M., Simpson G. R., Sarid R., Gao S. J., Stoiber H., Herrington C. S., Moore P. S., Schulz T. F. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol. 1997 Aug;71(8):5915–5921. doi: 10.1128/jvi.71.8.5915-5921.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 1996 Mar;2(3):342–346. doi: 10.1038/nm0396-342. [DOI] [PubMed] [Google Scholar]
  149. Renwick N., Halaby T., Weverling G. J., Dukers N. H., Simpson G. R., Coutinho R. A., Lange J. M., Schulz T. F., Goudsmit J. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS. 1998 Dec 24;12(18):2481–2488. doi: 10.1097/00002030-199818000-00018. [DOI] [PubMed] [Google Scholar]
  150. Rettig M. B., Ma H. J., Vescio R. A., Põld M., Schiller G., Belson D., Savage A., Nishikubo C., Wu C., Fraser J. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 1997 Jun 20;276(5320):1851–1854. doi: 10.1126/science.276.5320.1851. [DOI] [PubMed] [Google Scholar]
  151. Rezza G., Tchangmena O. B., Andreoni M., Bugarini R., Toma L., Bakary D. K., Glikoutou M., Sarmati L., Monini P., Pezzotti P. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis. 2000 Mar;27(3):159–164. doi: 10.1097/00007435-200003000-00008. [DOI] [PubMed] [Google Scholar]
  152. Risau W. Mechanisms of angiogenesis. Nature. 1997 Apr 17;386(6626):671–674. doi: 10.1038/386671a0. [DOI] [PubMed] [Google Scholar]
  153. Rose T. M., Strand K. B., Schultz E. R., Schaefer G., Rankin G. W., Jr, Thouless M. E., Tsai C. C., Bosch M. L. Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J Virol. 1997 May;71(5):4138–4144. doi: 10.1128/jvi.71.5.4138-4144.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Said J. W., Tasaka T., Takeuchi S., Asou H., de Vos S., Cesarman E., Knowles D. M., Koeffler H. P. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood. 1996 Oct 15;88(8):3124–3128. [PubMed] [Google Scholar]
  155. Salahuddin S. Z., Nakamura S., Biberfeld P., Kaplan M. H., Markham P. D., Larsson L., Gallo R. C. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science. 1988 Oct 21;242(4877):430–433. doi: 10.1126/science.2459779. [DOI] [PubMed] [Google Scholar]
  156. Samaniego F., Markham P. D., Gallo R. C., Ensoli B. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J Immunol. 1995 Apr 1;154(7):3582–3592. [PubMed] [Google Scholar]
  157. Simpson G. R., Schulz T. F., Whitby D., Cook P. M., Boshoff C., Rainbow L., Howard M. R., Gao S. J., Bohenzky R. A., Simmonds P. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet. 1996 Oct 26;348(9035):1133–1138. doi: 10.1016/S0140-6736(96)07560-5. [DOI] [PubMed] [Google Scholar]
  158. Sirianni M. C., Uccini S., Angeloni A., Faggioni A., Cottoni F., Ensoli B. Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma. Lancet. 1997 Jan 25;349(9047):255–255. doi: 10.1016/s0140-6736(05)64866-0. [DOI] [PubMed] [Google Scholar]
  159. Sitas F., Carrara H., Beral V., Newton R., Reeves G., Bull D., Jentsch U., Pacella-Norman R., Bourboulia D., Whitby D. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med. 1999 Jun 17;340(24):1863–1871. doi: 10.1056/NEJM199906173402403. [DOI] [PubMed] [Google Scholar]
  160. Smith N. A., Sabin C. A., Gopal R., Bourboulia D., Labbet W., Boshoff C., Barlow D., Band B., Peters B. S., de Ruiter A. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis. 1999 Sep;180(3):600–606. doi: 10.1086/314926. [DOI] [PubMed] [Google Scholar]
  161. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M. F., Clauvel J. P., Raphael M., Degos L. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995 Aug 15;86(4):1276–1280. [PubMed] [Google Scholar]
  162. Staskus K. A., Zhong W., Gebhard K., Herndier B., Wang H., Renne R., Beneke J., Pudney J., Anderson D. J., Ganem D. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol. 1997 Jan;71(1):715–719. doi: 10.1128/jvi.71.1.715-719.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Strauchen J. A., Hauser A. D., Burstein D., Jimenez R., Moore P. S., Chang Y. Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann Intern Med. 1996 Nov 15;125(10):822–825. doi: 10.7326/0003-4819-125-10-199611150-00006. [DOI] [PubMed] [Google Scholar]
  164. Stürzl M., Blasig C., Schreier A., Neipel F., Hohenadl C., Cornali E., Ascherl G., Esser S., Brockmeyer N. H., Ekman M. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer. 1997 Jul 3;72(1):68–71. doi: 10.1002/(sici)1097-0215(19970703)72:1<68::aid-ijc10>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  165. Stürzl M., Brandstetter H., Roth W. K. Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo. AIDS Res Hum Retroviruses. 1992 Oct;8(10):1753–1763. doi: 10.1089/aid.1992.8.1753. [DOI] [PubMed] [Google Scholar]
  166. Stürzl M., Hohenadl C., Zietz C., Castanos-Velez E., Wunderlich A., Ascherl G., Biberfeld P., Monini P., Browning P. J., Ensoli B. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst. 1999 Oct 20;91(20):1725–1733. doi: 10.1093/jnci/91.20.1725. [DOI] [PubMed] [Google Scholar]
  167. Tarte K., Olsen S. J., Rossi J. F., Legouffe E., Lu Z. Y., Jourdan M., Chang Y., Klein B. Kaposi's sarcoma-associated herpesvirus is not detected with immunosuppression in multiple myeloma. Blood. 1998 Sep 15;92(6):2186–2188. [PubMed] [Google Scholar]
  168. Tasaka T., Said J. W., Koeffler H. P. Absence of HHV-8 in prostate and semen. N Engl J Med. 1996 Oct 17;335(16):1237–1239. [PubMed] [Google Scholar]
  169. Tonin P., Weber B., Offit K., Couch F., Rebbeck T. R., Neuhausen S., Godwin A. K., Daly M., Wagner-Costalos J., Berman D. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med. 1996 Nov;2(11):1179–1183. doi: 10.1038/nm1196-1179. [DOI] [PubMed] [Google Scholar]
  170. Uthman A., Brna C., Weninger W., Tschachler E. No HHV8 in non-Kaposi's sarcoma mucocutaneous lesions from immunodeficient HIV-positive patients. Lancet. 1996 Jun 15;347(9016):1700–1701. doi: 10.1016/s0140-6736(96)91534-2. [DOI] [PubMed] [Google Scholar]
  171. Vaishnav Y. N., Wong-Staal F. The biochemistry of AIDS. Annu Rev Biochem. 1991;60:577–630. doi: 10.1146/annurev.bi.60.070191.003045. [DOI] [PubMed] [Google Scholar]
  172. Viviano E., Vitale F., Ajello F., Perna A. M., Villafrate M. R., Bonura F., Aricò M., Mazzola G., Romano N. Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in Sicily. AIDS. 1997 Apr;11(5):607–612. doi: 10.1097/00002030-199705000-00008. [DOI] [PubMed] [Google Scholar]
  173. Vogel J., Hinrichs S. H., Reynolds R. K., Luciw P. A., Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature. 1988 Oct 13;335(6191):606–611. doi: 10.1038/335606a0. [DOI] [PubMed] [Google Scholar]
  174. Vogelstein B., Fearon E. R., Hamilton S. R., Feinberg A. P. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science. 1985 Feb 8;227(4687):642–645. doi: 10.1126/science.2982210. [DOI] [PubMed] [Google Scholar]
  175. Wabinga H. R., Parkin D. M., Wabwire-Mangen F., Mugerwa J. W. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer. 1993 Apr 22;54(1):26–36. doi: 10.1002/ijc.2910540106. [DOI] [PubMed] [Google Scholar]
  176. Walts A. E., Shintaku I. P., Said J. W. Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol. 1990 Aug;94(2):170–175. doi: 10.1093/ajcp/94.2.170. [DOI] [PubMed] [Google Scholar]
  177. Weninger W., Partanen T. A., Breiteneder-Geleff S., Mayer C., Kowalski H., Mildner M., Pammer J., Stürzl M., Kerjaschki D., Alitalo K. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest. 1999 Feb;79(2):243–251. [PubMed] [Google Scholar]
  178. Whitby D., Boshoff C., Luppi M., Torelli G. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science. 1997 Dec 12;278(5345):1971–1973. [PubMed] [Google Scholar]
  179. Whitby D., Howard M. R., Tenant-Flowers M., Brink N. S., Copas A., Boshoff C., Hatzioannou T., Suggett F. E., Aldam D. M., Denton A. S. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995 Sep 23;346(8978):799–802. doi: 10.1016/s0140-6736(95)91619-9. [DOI] [PubMed] [Google Scholar]
  180. Whitby D., Luppi M., Barozzi P., Boshoff C., Weiss R. A., Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst. 1998 Mar 4;90(5):395–397. doi: 10.1093/jnci/90.5.395. [DOI] [PubMed] [Google Scholar]
  181. Whitby D., Luppi M., Sabin C., Barozzi P., Di Biase A. R., Balli F., Cucci F., Weiss R. A., Boshoff C., Torelli G. Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. Br J Cancer. 2000 Feb;82(3):702–704. doi: 10.1054/bjoc.1999.0983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Zahger D., Lotan C., Admon D., Klapholz L., Kaufman B., Shimon D., Woolfson N., Gotsman M. S. Very early appearance of Kaposi's sarcoma after cardiac transplantation in Sephardic Jews. Am Heart J. 1993 Oct;126(4):999–1000. doi: 10.1016/0002-8703(93)90721-k. [DOI] [PubMed] [Google Scholar]
  183. Zhu L., Wang R., Sweat A., Goldstein E., Horvat R., Chandran B. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology. 1999 Apr 10;256(2):381–392. doi: 10.1006/viro.1999.9674. [DOI] [PubMed] [Google Scholar]
  184. Ziegler J. L., Katongole-Mbidde E. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer. 1996 Jan 17;65(2):200–203. doi: 10.1002/(SICI)1097-0215(19960117)65:2<200::AID-IJC12>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  185. Ziegler J. L., Newton R., Katongole-Mbidde E., Mbulataiye S., De Cock K., Wabinga H., Mugerwa J., Katabira E., Jaffe H., Parkin D. M. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS. 1997 Nov;11(13):1619–1626. doi: 10.1097/00002030-199713000-00011. [DOI] [PubMed] [Google Scholar]
  186. Zietz C., Bogner J. R., Goebel F. D., Löhrs U. An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS. N Engl J Med. 1999 Jun 17;340(24):1923–1924. doi: 10.1056/NEJM199906173402415. [DOI] [PubMed] [Google Scholar]
  187. Zong J. C., Ciufo D. M., Alcendor D. J., Wan X., Nicholas J., Browning P. J., Rady P. L., Tyring S. K., Orenstein J. M., Rabkin C. S. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol. 1999 May;73(5):4156–4170. doi: 10.1128/jvi.73.5.4156-4170.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. de-The G., Lavoue M. F., Muenz L. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. IARC Sci Publ. 1978;(20):471–481. [PubMed] [Google Scholar]
  189. de-Thé G., Bestetti G., van Beveren M., Gessain A. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa. J Natl Cancer Inst. 1999 Nov 3;91(21):1888–1889. doi: 10.1093/jnci/91.21.1888. [DOI] [PubMed] [Google Scholar]

Articles from Philosophical Transactions of the Royal Society of London. Series B are provided here courtesy of The Royal Society

RESOURCES